/Companies

ProbiusDX

Fremont, US · Founded 2016 · Delaware corporation · 16 employees on LinkedIn · 7 known investors

Find your way into ProbiusDX

Sign up to see every warm intro you have to ProbiusDX

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ProbiusDX team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Probius develops Quantum Electrochemical Spectroscopy (QES), a label- and reagent-free electrochemical sensing technology that detects and quantifies thousands of analytes—proteins, metabolites, and cells—from microliter-scale biological samples in about 30 minutes. The platform generates digital representations of biological specimens and cloud-based multiplex assays intended to feed AI models of biology for biomarker discovery, drug development, and bioproduction quality control.

Founders & leadership

ProbiusDX was founded in 2016 by Chaitanya Gupta and Emmanuel Quevy.

CG
Chaitanya GuptaCo-founder, CTOCo-founder and CTO of ProbiusDX, which develops electrochemical sensing technology for high-throughput biochemical analysis of biological samples.
EQEmmanuel Quevy
Emmanuel QuevyCo-Founder and CEOCo-founder and CEO of ProbiusDX, which develops electrochemical sensing technology for detecting and quantifying biological analytes from small-scale samples.

Investors · 7

Reported raises · per SEC filings

Form D private placements

$2.4M disclosed across 1 round · 2025

▶$2.4MraisedAug 2025 · 21 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Chaitanya GuptaExecutive Officer, Director
  • Emmanuel QuevyExecutive Officer, Director
Offering amount
$25M
Amount sold
$2.4M
Sales commissions
$252K
First sale
Aug 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as ProbiusDX.

Frequently asked questions

What does ProbiusDX do?
Probius develops Quantum Electrochemical Spectroscopy (QES), a label- and reagent-free electrochemical sensing technology that detects and quantifies thousands of analytes—proteins, metabolites, and cells—from microliter-scale biological samples in about 30 minutes. The platform generates digital representations of biological specimens and cloud-based multiplex assays intended to feed AI models of biology for biomarker discovery, drug development, and bioproduction quality control.
Who founded ProbiusDX?
ProbiusDX was founded by Chaitanya Gupta, Emmanuel Quevy in 2016.
Who are ProbiusDX's investors?
ProbiusDX's investors include Cota Capital, Heuristic Capital Partners, Joyance Partners, Qubits Ventures, Silicon Catalyst, Social Starts, TSVC.
How much funding has ProbiusDX raised?
ProbiusDX has disclosed $2.4M raised across 1 round.
Where is ProbiusDX headquartered?
ProbiusDX is headquartered in Fremont, US.